Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-9606-00195
Entry Name
UniProt Accession
Theoretical PI
7.18
Molecular Weight
34234.86
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
NADH-cytochrome b5 reductase 3 soluble form
Protein Synonyms/Alias
B5R; Cytochrome b5 reductase; 1.6.2.2; Diaphorase-1;
Gene Name
CYB5R3
Gene Synonyms/Alias
DIA1;
Created Date
21-JUL-1986
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
2
Canonical
******MGAQLSTLG
[1][2]
N-Myristoylation
Organism
Homo sapiens (Human)
NCBI Taxa ID
9606
Reference
[1] Murakami K, Yubisui T, Takeshita M, Miyata T. The NH2-terminal structures ofhuman and rat liver microsomal NADH-cytochrome b5 reductases. J Biochem. 1989Feb;105(2):312-7.[PMID:2498303]
[2] Strittmatter P, Kittler JM, Coghill JE, Ozols J. Interaction ofnon-myristoylated NADH-cytochrome b5 reductase with cytochromeb5-dimyristoylphosphatidylcholine vesicles. J Biol Chem. 1993 Nov5;268(31):23168-71.[PMID:8226835]
Functional Description
Desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction.
Sequence Annotation
Domain: 40 152 FAD-binding FR-type.
Nucleotide-binding: 132 147 FAD.
Nucleotide-binding: 171 206 FAD.
Modified residue: 42 42 N6-acetyllysine.
Modified residue: 43 43 Phosphotyrosine.
Modified residue: 120 120 N6-acetyllysine.
Protein Length
301 AA.
Protein Sequence
(Canonical)
MGAQLSTLGH MVLFPVWFLY SLLMKLFQRS TPAITLESPD IKYPLRLIDR EIISHDTRRF  60
RFALPSPQHI LGLPVGQHIY LSARIDGNLV VRPYTPISSD DDKGFVDLVI KVYFKDTHPK  120
FPAGGKMSQY LESMQIGDTI EFRGPSGLLV YQGKGKFAIR PDKKSNPIIR TVKSVGMIAG  180
GTGITPMLQV IRAIMKDPDD HTVCHLLFAN QTEKDILLRP ELEELRNKHS ARFKLWYTLD  240
RAPEAWDYGQ GFVNEEMIRD HLPPPEEEPL VLMCGPPPMI QYACLPNLDH VGHPTERCFV  300
F                                                                  301
FASTA
(Canonical)
>LipidDB-9606-00195|P00387
MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRF
RFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPK
FPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAG
GTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLD
RAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFV
F
Gene Ontology
GO:0005737; C:cytoplasm; TAS:ProtInc
GO:0005783; C:endoplasmic reticulum; IDA:HPA
GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl
GO:0070062; C:extracellular vesicular exosome; IDA:UniProt
GO:0005833; C:hemoglobin complex; TAS:ProtInc
GO:0005811; C:lipid particle; IDA:UniProtKB
GO:0016020; C:membrane; IDA:UniProtKB
GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl
GO:0005741; C:mitochondrial outer membrane; TAS:Reactome
GO:0005739; C:mitochondrion; IDA:UniProt
GO:0043531; F:ADP binding; IEA:Ensembl
GO:0016208; F:AMP binding; IEA:Ensembl
GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; TAS:Reactome
GO:0071949; F:FAD binding; IDA:UniProtKB
GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
GO:0051287; F:NAD binding; IEA:Ensembl
GO:0008015; P:blood circulation; TAS:ProtInc
GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW
GO:0019852; P:L-ascorbic acid metabolic process; TAS:Reactome
GO:0044281; P:small molecule metabolic process; TAS:Reactome
GO:0006766; P:vitamin metabolic process; TAS:Reactome
GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Interpro
InterPro; IPR017927; Fd_Rdtase_FAD-bd
InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase
InterPro; IPR001834; NADH-Cyt_B5_reductase
InterPro; IPR008333; OxRdtase_FAD-bd_dom
InterPro; IPR001433; OxRdtase_FAD/NAD-bd
InterPro; IPR017938; Riboflavin_synthase-like_b-brl
Pfam
Pfam; PF00970; FAD_binding_6;
Pfam; PF00175; NAD_binding_1;
SMART
PROSITE
PROSITE; PS51384; FAD_FR;
PRINTS
PRINTS; PR00406; CYTB5RDTASE;
PRINTS; PR00371; FPNCR;